The use of uterotonic drugs during caesarean section

International Journal of Obstetric Anesthesia

Volumn 19, Issue 3, 2010, Pages 313-319

  Dyer, R A ^a   Van Dyk, D ^a   Dresner, A ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CARBETOCIN; CARBOPROST; ERGOMETRINE; ERGOMETRINE MALEATE; ERGOMETRINE PLUS OXYTOCIN; ERGOT ALKALOID; METHYLERGOMETRINE; MISOPROSTOL; OXYTOCIN; PHENYLEPHRINE; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; UTEROTONIC AGENT; VASOPRESSIN;

CESAREAN SECTION; CONTINUOUS INFUSION; CORONARY ARTERY SPASM; CRYSTALLOID; DIARRHEA; DOSE RESPONSE; DRUG BINDING; DRUG FATALITY; DRUG HALF LIFE; DRUG MECHANISM; DRUG POTENTIATION; FEVER; FLUSHING; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; HUMAN; HYPERTENSION; HYPOTENSION; MAXIMUM TOLERATED DOSE; NAUSEA; NAUSEA AND VOMITING; NONHUMAN; OBSTETRIC ANESTHESIA; POSTPARTUM HEMORRHAGE; PUERPERIUM; PULMONARY HYPERTENSION; RECOMMENDED DRUG DOSE; REVIEW; SHIVERING; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; UTERINE ATONY; VAGINAL DELIVERY; VOMITING;

ADULT; CESAREAN SECTION; ERGONOVINE; ERGOT ALKALOIDS; FEMALE; HUMANS; OXYTOCICS; OXYTOCIN; POSTOPERATIVE NAUSEA AND VOMITING; PREGNANCY; PROSTAGLANDINS; UTERINE DISEASES; UTERINE INERTIA;

EID: 77954219419     PISSN: 0959289X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijoa.2010.04.011     Document Type: Review

References (67)

1. P. Clyburn, S. Morris, and J. Hall Anaesthesia and safe motherhood Anaesthesia 62 Suppl 1 2007 21 25
2. F. Arias Pharmacology of oxytocin and prostaglandins Clin Obstet Gynecol 43 2000 455 468
3. R.E. Garfield, M.S. Kannan, and E.E. Daniel Gap junction formation in myometrium: control by estrogens, progesterone, and prostaglandins Am J Physiol 238 1980 C81 C89
4. J. Gutkowska, M. Jankowski, C. Lambert, S. Mukaddam-Daher, H.H. Zingg, and S.M. McCann Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart Proc Natl Acad Sci USA 94 1997 11704 11709 (Pubitemid 27451062)
5. M. Jankowski, F. Hajjar, and S.A. Kawas Rat heart: a site of oxytocin production and action Proc Natl Acad Sci USA 95 1998 14558 14563
6. S. Mukaddam-Daher, Y.L. Yin, J. Roy, J. Gutkowska, and R. Cardinal Negative inotropic and chronotropic effects of oxytocin Hypertension 38 2001 292 296
7. O.P. Rosaeg, N.J. Cicutti, and R.S. Labow The effect of oxytocin on the contractile force of human atrial trabeculae Anesth Analg 86 1998 40 44
8. D. Bergum, H. Lonnee, and T.F. Hakli Oxytocin infusion: acute hyponatraemia, seizures and coma Acta Anaesthesiol Scand 53 2009 826 827
9. F.R. Weis Jr., R. Markello, B. Mo, and P. Bochiechio Cardiovascular effects of oxytocin Obstet Gynecol 46 1975 211 214
10. N.J. Secher, P. Arnsbo, and L. Wallin Haemodynamic effects of oxytocin (syntocinon) and methyl ergometrine (methergin) on the systemic and pulmonary circulations of pregnant anaesthetized women Acta Obstet Gynecol Scand 57 1978 97 103
11. E. Langesaeter, L.A. Rosseland, and A. Stubhaug Hemodynamic effects of oxytocin during cesarean delivery Int J Gynaecol Obstet 95 2006 46 47
12. R.A. Dyer, A.R. Reed, and D. van Dyk Hemodynamic effects of ephedrine, phenylephrine and the coadministration of phenylephrine and oxytocin during spinal anesthesia for elective cesarean section Anesthesiology 111 2009 753 765
13. T.L. Archer, K. Knape, D. Liles, A.S. Wheeler, and B. Carter The hemodynamics of oxytocin and other vasoactive agents during neuraxial anesthesia for cesarean delivery Int J Obstet Anesth 17 2008 247 254
14. A.J. Pinder, M. Dresner, C. Calow, G.D. Shorten, J. O'Riordan, and R. Johnson Haemodynamic changes caused by oxytocin during caesarean section under spinal anaesthesia Int J Obstet Anesth 11 2002 156 159
15. R.A. Dyer, J.L. Piercy, A.R. Reed, C.J. Lombard, L.K. Schoeman, and M.F. James Hemodynamic changes associated with spinal anesthesia for cesarean delivery in severe preeclampsia Anesthesiology 108 2008 802 811
16. T.A. Thomas, and G.M. Cooper Maternal deaths from anaesthesia. An extract from why mothers die 1997-1999, the confidential enquiries into maternal deaths in the United Kingdom Br J Anaesth 89 2002 499 508
17. Lamacraft G. Anaesthesia related deaths. In Pattinson RC, ed. Saving mothers: fourth report on confidential enquiries into maternal deaths in South Africa. Department of Health, Pretoria, Republic of South Africa 2010: 137.
18. C.L. Fortner, E.S. Manley Jr., and R.A. Woodbury Effects of synthetic oxytocin with and without preservatives upon coronary blood flow in the dog J Pharmacol Exp Ther 165 1969 258 266
19. M.C. Svanstrom, B. Biber, M. Hanes, G. Johansson, U. Naslund, and E.M. Balfors Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during Caesarean section Br J Anaesth 100 2008 683 689
20. R. Dogan, A. Birdane, A. Bilir, S. Ekemen, and B. Tanriverdi Frequency of electrocardiographic changes indicating myocardial ischemia during elective cesarean delivery with regional and general anesthesia: detection based on continuous Holter monitoring and serum markers of ischemia J Clin Anesth 20 2008 347 351
21. M. Jonsson, U. Hanson, C. Lidell, and S. Norden-Lindeberg ST depression at caesarean section and the relation to oxytocin dose. A randomised controlled trial BJOG 117 2010 76 83
22. J.B. Sartain, J.J. Barry, P.W. Howat, D.I. McCormack, and M. Bryant Intravenous oxytocin bolus of 2 units is superior to 5 units during elective Caesarean section Br J Anaesth 101 2008 822 826
23. J.S. Thomas, S.H. Koh, and G.M. Cooper Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section Br J Anaesth 98 2007 116 119
24. E. Langesaeter, M. Dragsund, and L.A. Rosseland Regional anaesthesia for a Caesarean section in women with cardiac disease: a prospective study Acta Anaesthesiol Scand 54 2010 46 54
25. J.C. Carvalho, M. Balki, J. Kingdom, and R. Windrim Oxytocin requirements at elective cesarean delivery: a dose-finding study Obstet Gynecol 104 2004 1005 1010
26. A.J. Butwick, L. Coleman, S.E. Cohen, E.T. Riley, and B. Carvalho Minimum effective bolus dose of oxytocin during elective caesarean delivery Br J Anaesth 104 2010 338 343
27. M. Balki, M. Ronayne, and S. Davies Minimum oxytocin dose requirement after cesarean delivery for labor arrest Obstet Gynecol 107 2006 45 50
28. R. Abdul-Karim, and N.S. Assali Renal function in human pregnancy. V. Effects of oxytocin on renal hemodynamics and water and electrolyte excretion J Lab Clin Med 57 1961 522 532
29. George RB, McKeen D, Chaplin AC, McLeod L. Up-down determination of the ED90 of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing Cesarean delivery. Can J Anesth, in press.
30. Royal College of Obstetricians and Gynaecologists. Prevention and treatment of postpartum haemorrhage Royal College of Obstetricians and Gynaecologists' Green-top Guideline no.52, 2009. http://www.rcog.org.uk.
31. E. Langesaeter, L.A. Rosseland, and A. Stubhaug Haemodynamic effects of repeated doses of oxytocin during Caesarean delivery in healthy parturients Br J Anaesth 103 2009 260 262
32. S. Phaneuf, L.B. Rodriguez, R.L. TambyRaja, I.Z. MacKenzie, and B.A. Lopez Loss of myometrial oxytocin receptors during oxytocin-induced and oxytocin-augmented labour J Reprod Fertil 120 2000 91 97
33. J.K. Magalhaes, J.C. Carvalho, R.K. Parkes, J. Kingdom, Y. Li, and M. Balki Oxytocin pretreatment decreases oxytocin-induced myometrial contractions in pregnant rats in a concentration-dependent but not time-dependent manner Reprod Sci 16 2009 501 508
34. Balki M, Cristian A, Parkes RK, Kingdom J, Carvalho JC. Oxytocin preexposure of pregnant rat myometrium reduces the efficacy of oxytocin but not of ergonovine or carboprost. Washington, USA: Society of Obstetric Anesthesia and Perinatology Annual Meeting; 2009. A12.
35. B.A. Brindlye, and R.J. Sokol Induction and augmentation: basis and methods for current practice Obstet Gynecol Surv 43 1988 730 743
36. G. Sweeney, A.M. Holbrook, and M. Levine Pharmacokinetics of carbetocin, a long-acting oxytocin analogue, in non-pregnant women Curr Ther Res 47 1990 520 540
37. W. Rath Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin Eur J Obstet Gynecol Reprod Biol 147 2009 15 20
38. J. Dansereau, A.K. Joshi, and M.E. Helewa Double-blind comparison of carbetocin versus oxytocin in preventing uterine atony post caesarean section Am J Obstet Gynecol 180 1999 670 676
39. P.W. van Dongen, M.M. Verbruggen, A.N. de Groot, J. van Roosmalen, J.M. Sporken, and M. Schulz Ascending dose tolerance study of intramuscular carbetocin administered after normal vaginal birth Eur J Obstet Gynecol Reprod Biol 77 1998 181 187
40. L.L. Su, Y.S. Chong, and M. Samuel Oxytocin agonists for preventing postpartum haemorrhage Cochrane Database Syst Rev 2007 (Art. No.: CD005457)
41. M. Vercauteren, S. Palit, F. Soetens, Y. Jacquemyn, and S. Alahuhta Anaesthesiological considerations on tocolytic and uterotonic therapy in obstetrics Acta Anaesthesiol Scand 53 2009 701 709
42. C.E. den Hertog, A.N. de Groot, and P.W. van Dongen History and use of oxytocics Eur J Obstet Gynecol Reprod Biol 94 2001 8 12
43. A.N. de Groot, P.W. van Dongen, T.B. Vree, Y.A. Hekster, and J. van Roosmalen Ergot alkaloids. Current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology Drugs 56 1998 523 535
44. Y.H. Lin, K.M. Seow, J.L. Hwang, and H.H. Chen Myocardial infarction and mortality caused by methylergonovine Acta Obstet Gynecol Scand 84 2005 1022
45. Y. Hayashi, T. Ibe, and H. Kawato Postpartum acute myocardial infarction induced by ergonovine administration Intern Med 42 2003 983 986
46. World Health Organisation. WHO Guidelines for the Management of Postpartum Haemorrhage and Retained Placenta, 2009. http://whqlibdoc.who.int/ publications/2009/9789241598514-eng.pdf.
47. M. Balki, and J.C. Carvalho Intraoperative nausea and vomiting during cesarean section under regional anesthesia Int J Obstet Anesth 14 2005 230 241
48. P.R. Myerscough, and H. Schild Quantitative assays of oxytocic drugs on the human postpartum uterus Br J Pharmacol Chemother 13 1958 207 212
49. S. Takagi, T. Yoshida, and Y. Togo The effects of intramyometrial injection of prostaglandin F2alpha on severe post-partum hemorrhage Prostaglandins 12 1976 565 579
50. S.L. Corson, and R.J. Bolognese Postpartum uterine atony treated with prostaglandins Am J Obstet Gynecol 129 1977 918 919
51. R.H. Hayashi, M.S. Castillo, and M.L. Noah Management of severe postpartum hemorrhage due to uterine atony using an analogue of prostaglandin F2 alpha Obstet Gynecol 58 1981 426 429
52. C.R. Harber, D.M. Levy, S. Chidambaram, and M.B. Macpherson Life-threatening bronchospasm after intramuscular carboprost for postpartum haemorrhage BJOG 114 2007 366 368
53. L.H. Andersen, and N.J. Secher Pattern of total and regional lung function in subjects with bronchoconstriction induced by 15-me PGF2 alpha Thorax 31 1976 685 692
54. M.M. Chou, and I.Z. MacKenzie A prospective, double-blind, randomized comparison of prophylactic intramyometrial 15-methyl prostaglandin F2 alpha, 125 micrograms, and intravenous oxytocin, 20 units, for the control of blood loss at elective cesarean section Am J Obstet Gynecol 171 1994 1356 1360
55. L. Granstrom, G. Ekman, and U. Ulmsten Intravenous infusion of 15 methyl-prostaglandin F2 alpha (Prostinfenem) in women with heavy post-partum hemorrhage Acta Obstet Gynecol Scand 68 1989 365 367
56. N.J. Secher, P. Thayssen, P. Arnsbo, and J. Olsen Effect of prostaglandin E2 and F2alpha on the systemic and pulmonary circulation in pregnant anesthetized women Acta Obstet Gynecol Scand 61 1982 213 218
57. G.J. Hofmeyr, and A.M. Gulmezoglu Misoprostol for the prevention and treatment of postpartum haemorrhage Best Pract Res Clin Obstet Gynaecol 22 2008 1025 1041
58. G.J. Hofmeyr, A.M. Gulmezoglu, N. Novikova, V. Linder, S. Ferreira, and G. Piaggio Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects Bull World Health Organ 87 2009 666 677
59. P. O'Brien, H. El Refaey, A. Gordon, M. Geary, and C.H. Rodeck Rectally administered misoprostol for the treatment of postpartum hemorrhage unresponsive to oxytocin and ergometrine: a descriptive study Obstet Gynecol 92 1998 212 214
60. J. Hamm, Z. Russell, T. Botha, S.J. Carlan, and K. Richichi Buccal misoprostol to prevent hemorrhage at cesarean delivery: a randomized study Am J Obstet Gynecol 192 2005 1404 1406
61. G. Acharya, M.T. Al Sammarai, N. Patel, A. Al Habib, and T. Kiserud A randomized, controlled trial comparing effect of oral misoprostol and intravenous syntocinon on intra-operative blood loss during cesarean section Acta Obstet Gynecol Scand 80 2001 245 250
62. P.S. Ramsey, B.B. Hogg, K.G. Savage, D.D. Winkler, and J. Owen Cardiovascular effects of intravaginal misoprostol in the mid trimester of pregnancy Am J Obstet Gynecol 183 2000 1100 1102
63. J. Blum, B. Winikoff, and S. Raghavan Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial Lancet 375 2010 217 223
64. P. Beukens, and F. Althabe Post-partum haemorrhage: beyond the confrontation between misoprostol and oxytocin Lancet 375 2010 176 178
65. W.D. Writer, and T.F. Baskett Postpartum hemorrhage S. Datta, Anesthetic and obstetric management of high-risk pregnancy 2nd ed. 1996 Mosby St Louis 110 113
66. J.E. Moodie, and D.D. Moir Ergometrine, oxytocin and extradural analgesia Br J Anaesth 48 1976 571 574
67. S. McDonald, J.M. Abbott, and S.P. Higgins Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour Cochrane Database Syst Rev 2004 (CD000201)